A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
- 28 February 1995
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 160 (2) , 178-184
- https://doi.org/10.1016/0008-8749(95)80025-e
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activityPublished by Elsevier ,2005
- Angiogenesis inhibition suppresses collagen arthritis.The Journal of Experimental Medicine, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Identification of an Inhibitor of Neovascularization from CartilageScience, 1990
- Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexateArthritis & Rheumatism, 1989
- Control of Angiogenesis with Synthetic Heparin SubstitutesScience, 1989
- Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.Journal of Clinical Investigation, 1989
- Angiogenic FactorsScience, 1987
- Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cellsClinical Immunology and Immunopathology, 1984
- Humoral and Cellular Sensitivity to Collagen in Type II Collagen-Induced Arthritis in RatsJournal of Clinical Investigation, 1978